Kits Eyecare Ltd. received a positive analyst update from Haywood Securities, which raised its price target to $26.00 from $20.00, reflecting strengthening earnings momentum and improved operating performance. The revision signals increased confidence in the company’s growth trajectory and profitability outlook.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
